Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 6Recruiting 3Terminated 2Unknown 1Active not recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Dermatologic 39Thoracic 5Gastrointestinal 4Head & Neck 3Genitourinary 3NET 2Gynecologic 2Endocrine 2Breast 2Sarcoma 1Other solid neoplasm 1Lymphoid 1CNS 1

Conditions

Prostatic Neoplasms 957Urinary Bladder Neoplasms 264Carcinoma, Renal Cell 251Kidney Neoplasms 147Carcinoma, Transitional Cell 129Breast Neoplasms 127Neoplasms 122Colorectal Neoplasms 97Ovarian Neoplasms 90Melanoma 85Carcinoma, Non-Small-Cell Lung 84Lung Neoplasms 81Neoplasm Metastasis 79Pancreatic Neoplasms 68Non-Muscle Invasive Bladder Neoplasms 68Uterine Cervical Neoplasms 58Stomach Neoplasms 55Head and Neck Neoplasms 51Squamous Cell Carcinoma of Head and Neck 47Endometrial Neoplasms 47Adenocarcinoma 45Esophageal Neoplasms 44Testicular Neoplasms 42Carcinoma, Hepatocellular 41Sarcoma 39Disease 33Triple Negative Breast Neoplasms 32Liver Neoplasms 30Colonic Neoplasms 29Metastatic Castration-resistant Prostate Cancer 25

Interventions

cemiplimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Uveal Melanoma × Genitourinary × Clear all
NCT04792463 2026-03-09

Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome

Ohio State University

Recruiting
500 enrolled
DermatologicGastrointestinalGenitourinaryOther solid neoplasmThoracic

Uveal Melanoma, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Melanoma, Mesothelioma, Cholangiocarcinoma

NCT06022029 2025-12-24

ON-5001

OncoNano Medicine, Inc.

Phase 1 Recruiting
168 enrolled
BreastDermatologicGenitourinaryGynecologicHead & NeckLymphoid

Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Bites and Stings, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma in Situ, Uterine Cervical Neoplasms, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Melanoma, Neoplasm Metastasis, Neoplasms, Recurrence, Skin Neoplasms, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Triple Negative Breast Neoplasms

NCT06805825 2025-09-23

A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

Novelty Nobility, Inc.

Phase 1 Recruiting
67 enrolled
DermatologicEndocrineGastrointestinalGenitourinaryNETSarcomaThoracic

Uveal Melanoma, Carcinoma, Renal Cell, Carcinoma, Adenoid Cystic, Piebaldism, Neuroendocrine Tumors, Gastrointestinal Stromal Tumors, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡